What does this research mean for the field?

Gut microbiota significantly influences cancer initiation, progression, and therapeutic response by modulating the tumor microenvironment and immune system, and microbiome-targeted strategies can potentially improve immunotherapy outcomes. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the mechanisms by which gut microbiota influences cancer development, immune evasion, and response to immune checkpoint inhibitor therapies, alongside potential microbiome-modulating interventions.

September 5, 2026npj Precision OncologyOpen Access

Gut microbiota and the immune battlefield of cancer

View Full Paper

Ask AI

Bookmark

Authors

XWXinlin Wang KZKui Zhong XHXiao Huang

Discussion

Member takes

Overview

Narrative review uncovers gut microbiota mechanisms regulating cancer immunity and therapy response, highlighting microbial interventions to improve immunotherapy outcomes.

Key Points

To review the mechanisms by which gut microbiota influences cancer development, immune evasion, and response to immune checkpoint inhibitor therapies, alongside potential microbiome-modulating interventions.
Synthesized evidence detailing microbial interactions with innate and adaptive immunity across cancer initiation and progression.
Evaluated molecular mechanisms including microbial metabolites, pattern-recognition receptor signaling, epigenetic reprogramming, and extracellular vesicles.
Examined therapeutic microbiome-targeted approaches, including fecal microbiota transplantation, probiotics, and dietary interventions.
Dysbiosis alters the tumor microenvironment through metabolic and epigenetic reprogramming, pattern-recognition receptor signaling, and intratumoral bacterial colonization.
Specific gut microbiota profiles dictate responsiveness and resistance patterns during immune checkpoint inhibitor treatment.
Interventions such as fecal microbiota transplantation, probiotic supplementation, and targeted dietary regimens can favorably remodel the microbiome to enhance anti-tumor therapeutic efficacy.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6a9bd3a66b95aff0620eadd9 https://doi.org/10.1038/s41698-026-01684-8

View Full Paper

Ask AI

Bookmark

September 5, 2026npj Precision OncologyOpen Access

Gut microbiota and the immune battlefield of cancer

View Full Paper

Ask AI

Bookmark

Authors

XWXinlin Wang KZKui Zhong XHXiao Huang

Discussion

Member takes

Overview

Narrative review uncovers gut microbiota mechanisms regulating cancer immunity and therapy response, highlighting microbial interventions to improve immunotherapy outcomes.

Key Points

To review the mechanisms by which gut microbiota influences cancer development, immune evasion, and response to immune checkpoint inhibitor therapies, alongside potential microbiome-modulating interventions.
Synthesized evidence detailing microbial interactions with innate and adaptive immunity across cancer initiation and progression.
Evaluated molecular mechanisms including microbial metabolites, pattern-recognition receptor signaling, epigenetic reprogramming, and extracellular vesicles.
Examined therapeutic microbiome-targeted approaches, including fecal microbiota transplantation, probiotics, and dietary interventions.
Dysbiosis alters the tumor microenvironment through metabolic and epigenetic reprogramming, pattern-recognition receptor signaling, and intratumoral bacterial colonization.
Specific gut microbiota profiles dictate responsiveness and resistance patterns during immune checkpoint inhibitor treatment.
Interventions such as fecal microbiota transplantation, probiotic supplementation, and targeted dietary regimens can favorably remodel the microbiome to enhance anti-tumor therapeutic efficacy.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6a9bd3a66b95aff0620eadd9 https://doi.org/10.1038/s41698-026-01684-8

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark